NTNX vs TECH · P/E 108, rev $2.54B vs P/E 65, rev $1.22B
Nutanix Inc (NTNX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Nutanix Inc (NTNX) is a software - infrastructure company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NTNX revenue for 2025-07-31 was $2.54B. Net income was $188.4M. Revenue was up 18.1% from 2024-07-31 to 2025-07-31. NTNX currently screens at market cap $18.74B and trailing P/E 107.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NTNX currently screens at market cap $18.74B and trailing P/E 107.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NTNX and TECH stock pages for the full models.
Not investment advice.